Italy
Who we are
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer Without Liver Metastases
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
Sotorasib and Panitumumab Versus Investigator’s Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation (CodeBreak 300)
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
